Proper implementation of e-drug ordering needed
Despite high hopes that computerized medication ordering and monitoring systems can help hospitals reduce errors, recent analyses find just the opposite may be true.
Washington, D.C.-Despite high hopes that computerized medication ordering and monitoring systems can help hospitals reduce errors in drug prescribing and administration, recent analyses find just the opposite may be true. A study conducted at the Veterans Hospital in Salt Lake City, published in May in the Archives of Internal Medicine, found that some kind of prescribing error or adverse event occurred with almost half of the patients admitted to the hospital. Its computer system helped eliminate problems related to physician handwriting, but not those involved with administering medications or selecting correct drugs and doses.
Another study from the University of Pennsylvania School of Medicine found that computerized physician order entry systems may actually generate medication errors by displaying incomplete and confusing information and using inflexible ordering formats. And the U.S. Pharmacopeia reported in December 2004 that nearly 20% of hospital and health system medication errors involve computerization or automation.
Experts maintain that the solution lies not in fixing the software but in paying more attention to properly implementing electronic drug ordering programs. Better information systems also will help.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
